List 2.
• Endocrine disease known to cause heart muscle disease (including infants of diabetic mothers). |
• A history of rheumatic fever. |
• Toxic exposures known to cause heart muscle disease (e.g., anthracyclines, mediastinal radiation, iron overload, or heavy metal exposure). |
• HIV infection or born to an HIV positive mother. |
• Kawasaki disease. |
• Congenital heart defects unassociated with malformation syndromes (e.g., valvar heart disease or congenital coronary artery malformations). |
• Immunologic disease. |
• Invasive cardiothoracic procedures or major surgery during the preceding month except those specifically related to cardiomyopathy including LVAD, ECMO and AICD placement. |
• Uremia, active or chronic. |
• Abnormal ventricular size or function that can be attributed to intense physical training or chronic anemia. |
• Chronic arrhythmia unless there are studies documenting inclusion criteria prior to the onset of arrhythmia (except a patient with chronic arrhythmia, subsequently ablated, whose cardiomyopathy persists after two months is not to be excluded). |
• Malignancy. |
• Pulmonary parenchymal or vascular disease (e.g., cystic fibrosis, cor pulmonale, or pulmonary hypertension). |
• Ischemic coronary vascular disease. |
• Age less than 18 years. |
• Association with drugs known to cause hypertrophy (e.g., growth hormone, corticosteroids or cocaine) |
• Left ventricular assist device; extracorporeal membrane oxygenation; automatic implantable cardioverter defibrillator. |